Ryan K Berglund

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Optimal prostate biopsy regimen
    Ryan K Berglund
    Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH, USA
    Curr Urol Rep 13:455-9. 2012
  2. doi request reprint Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer
    Ryan K Berglund
    Glickman Urologic and Kidney Insititute, Cleveland, OH, USA
    BJU Int 110:834-9. 2012
  3. doi request reprint Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109
    Ryan K Berglund
    Department of Urology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 79:633-7. 2012
  4. ncbi request reprint Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland, OH 44195, USA
    Eur Urol 50:607-8. 2006
  5. doi request reprint Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment
    Ranko Miocinovic
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 77:946-50. 2011
  6. ncbi request reprint Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Urol 177:526-29; discussion 529-30. 2007
  7. doi request reprint Utility of percent free prostate-specific antigen in repeat prostate biopsy
    Byron H Lee
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 78:386-91. 2011
  8. doi request reprint A practical guide to prostate cancer diagnosis and management
    Matthew N Simmons
    Glickman Urological and Kidney Institute, Q10 1, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 78:321-31. 2011
  9. ncbi request reprint Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 67:1253-6. 2006
  10. ncbi request reprint Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Eur Urol 50:372-4. 2006

Detail Information

Publications10

  1. doi request reprint Optimal prostate biopsy regimen
    Ryan K Berglund
    Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, OH, USA
    Curr Urol Rep 13:455-9. 2012
    ..Furthermore, the detection of small volume, high grade cancers may widen the latency interval in which a clinically significant tumor may be detectable and curable...
  2. doi request reprint Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer
    Ryan K Berglund
    Glickman Urologic and Kidney Insititute, Cleveland, OH, USA
    BJU Int 110:834-9. 2012
    ..The study alerts the practising urologist to the risk of quinolone-resistant E. coli in the setting of transrectally placed transponders. Furthermore, it proposes an antibiotic regimen that should reduce this risk...
  3. doi request reprint Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109
    Ryan K Berglund
    Department of Urology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 79:633-7. 2012
    ..The optimal management for clinical stage T3 and T4 N0,M0 prostate cancer is uncertain...
  4. ncbi request reprint Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine: part 2
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland, OH 44195, USA
    Eur Urol 50:607-8. 2006
  5. doi request reprint Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment
    Ranko Miocinovic
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 77:946-50. 2011
    ..To examine the ability of surgery as initial management in avoiding androgen deprivation therapy (ADT) in patients with high-risk localized prostate cancer...
  6. ncbi request reprint Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Urol 177:526-29; discussion 529-30. 2007
    ..We compared 5-year treatment failure rates in patients with low, intermediate and high risk disease who underwent radical prostatectomy with or without pelvic lymph node dissection...
  7. doi request reprint Utility of percent free prostate-specific antigen in repeat prostate biopsy
    Byron H Lee
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Urology 78:386-91. 2011
    ..To assess the utility of the percent free prostate-specific antigen (%fPSA) for the prediction of prostate cancer in men undergoing repeat biopsy...
  8. doi request reprint A practical guide to prostate cancer diagnosis and management
    Matthew N Simmons
    Glickman Urological and Kidney Institute, Q10 1, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 78:321-31. 2011
    ..Screening, diagnosis, and management of prostate cancer can be complicated, with no clear consensus about key issues. We present our approach, which reflects the guidelines of the American Urological Association (AUA)...
  9. ncbi request reprint Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 67:1253-6. 2006
    ..We report on the feasibility of RP as a primary treatment modality for locally advanced disease...
  10. ncbi request reprint Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine
    Ryan K Berglund
    Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Eur Urol 50:372-4. 2006
    ..While bony metastasis of nonseminomatous germ cell tumors is rare, resection with spinal reconstruction can be accomplished with acceptable morbidity...